Robert Nelsen
Affiliations
- at Boundless Bio Inc. (BOLD), 2024-04-04
- Large Shareholder, Director at Prime Medicine Inc. (PRME), 2024-02-20
- Large Shareholder, Director at Sana Biotechnology Inc. (SANA), 2024-02-12
- Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
- Large Shareholder, Director at Lyell Immunopharma Inc. (LYEL), 2023-09-08
- Large Shareholder at Da32 Life Science Tech Acquisition Corp. (DALS), 2023-08-11
- Large Shareholder, Director at Vir Biotechnology Inc. (VIR), 2023-05-24
- Large Shareholder at Codiak Biosciences Inc. (CDAK), 2022-09-15
- Large Shareholder at Erasca Inc. (ERAS), 2021-07-21
- Large Shareholder at Beam Therapeutics Inc. (BEAM), 2021-06-29
- Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-23
- Director at Denali Therapeutics Inc. (DNLI), 2021-06-04
- Large Shareholder, Director at Karuna Therapeutics Inc. (KRTX), 2021-04-15
- Director at Revolution Healthcare Acquisition Corp. (REVH), 2021-03-17
- Large Shareholder at 908 Devices Inc. (MASS), 2020-12-23
- Large Shareholder at Quanterix Corp (QTRX), 2020-11-25
- Large Shareholder at Metacrine Inc. (MTCR), 2020-09-22
- Director at Unity Biotechnology Inc. (UBX), 2020-06-22
- Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
- Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-23
- Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
- Large Shareholder at Gossamer Bio Inc. (GOSS), 2019-02-12
- Large Shareholder at Twist Bioscience Corp (TWST), 2018-11-06
- Large Shareholder at Scholar Rock Holding Corp (SRRK), 2018-06-01
- Other at Pulmatrix Inc. (PULM), 2018-04-12
- Director at Juno Therapeutics Inc. (JUNO), 2018-03-07
- Director at Agios Pharmaceuticals Inc (AGIO), 2017-03-07
- Large Shareholder at Xtera Communications Inc. (XCOM), 2016-10-13
- Large Shareholder at Impinj Inc (PI), 2016-08-31
- Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
- Director at Sage Therapeutics Inc. (SAGE), 2015-11-12
- Large Shareholder at Adesto Technologies Corp (IOTS), 2015-11-04
- Large Shareholder at Vbi Vaccines Inc. (VBIV), 2015-08-17
- Other at Kythera Biopharmaceuticals Inc (KYTH), 2015-03-26
- Large Shareholder, Director at Bellerophon Therapeutics Inc. (BLPH), 2015-02-24
- Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
- Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
- Large Shareholder, Director at Fate Therapeutics Inc (FATE), 2013-10-07
- Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
- Large Shareholder, Director at Neurogesx Inc (NGSX), 2012-06-12
- Large Shareholder at Trubion Pharmaceuticals Inc (TRBN), 2010-11-01
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| PRME | $6.25 | 3,200,000 | Large Shareholder, Director | 3,200,000 | 2024-02-15 | Filing | |
| SANA | $5.50 | 727,272 | Large Shareholder, Director | 12,446,022 | 2024-02-08 | Filing | |
| SANA | $5.50 | 727,272 | Large Shareholder, Director | 12,446,022 | 2024-02-08 | Filing | |
| SANA | $5.50 | 363,637 | Large Shareholder, Director | 10,667,387 | 2024-02-08 | Filing | |
| PRME | $17.00 | 400,000 | Large Shareholder, Director | 6,128,297 | 2022-10-24 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| AGIO | $49.43 | 40 | Director | 0 | 2017-03-06 | Filing | |
| AGIO | $52.15 | 400 | Director | 40 | 2017-03-03 | Filing | |
| AGIO | $51.34 | 8,734 | Director | 440 | 2017-03-03 | Filing | |
| AGIO | $50.69 | 31,425 | Director | 9,174 | 2017-03-03 | Filing | |
| AGIO | $50.18 | 20,237 | Director | 40,599 | 2017-02-28 | Filing |